Metabolic syndrome underlying mechanisms and drug therapies /

Saved in:
Bibliographic Details
Corporate Author: ebrary, Inc
Other Authors: Wang, Minghan, 1966-
Format: Electronic eBook
Language:English
Published: Hoboken, N.J. : John Wiley & Sons, c2011.
Subjects:
Online Access:An electronic book accessible through the World Wide Web; click to view
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000 a 4500
001 0000130097
005 20171002061011.0
006 m u
007 cr cn|||||||||
008 100507s2011 njua sb 001 0 eng d
010 |z  2010019505 
020 |z 9780470343425 (cloth) 
020 |z 9780470910009 (e-book) 
035 |a (CaPaEBR)ebr10441458 
035 |a (OCoLC)696237308 
040 |a CaPaEBR  |c CaPaEBR 
050 1 4 |a RC662.4  |b .M53 2011eb 
082 0 4 |a 616.3/99  |2 22 
245 0 0 |a Metabolic syndrome  |h [electronic resource] :  |b underlying mechanisms and drug therapies /  |c edited by Minghan Wang. 
260 |a Hoboken, N.J. :  |b John Wiley & Sons,  |c c2011. 
300 |a xiii, 494 p. :  |b ill. 
504 |a Includes bibliographical references and index. 
505 0 |a Gut as an endocrine organ : the role of nutrient-sensing in energy metabolism / Minghan Wang -- Central glucose sensing and control of food intake and energy homeostasis / Lourdes Mounien and Bernard Thorens -- Abnormalities in insulin secretion in type 2 diabetes mellitus / Taly Meas and Pierre-Jean Guillausseau -- Adipokine production by adipose tissue : a novel target for treating metabolic syndrome and its sequelae / Vanessa DeClercq ... [et al.] -- Hepatic metabolic dysfunctions in type 2 diabetes : insulin resistance and impaired glucose production and lipid synthesis / Ruojing Yang -- Energy metabolism in skeletal muscle and its link to insulin resistance / Minghan Wang -- Mechanisms and complications of metabolic syndrome / Minghan Wang -- Emerging therapeutic approaches for dyslipidemia associated with high LDL and low HDL / Margrit Schwarz and Jae B. Kim -- Mechanism of action of niacin : implications for atherosclerosis and drug discovery / Devan Marar ... [et al.] -- Current anti-diabetic therapies and mechanisms / Minghan Wang -- GLP-1 biology, signaling mechanisms, physiology, and clinical studies / Remy Burcelin ... [et al.] -- Dipeptidyl peptidase IV inhibitors for treatment of diabetes / McIntosh, C.H.S. ... [et al.] -- Sodium glucose co-transporter 2 inhibitors / Margaret Ryan and Serge A. Jabbour -- Fibroblast growth factor 21 as a novel metabolic regulator / Radmila Micanovic, James D. Dunbar, and Alexei Kharitonenkov -- Sirtuins as potential drug targets for metabolic diseases / Qiang Tong -- 11-hydroxysteroid dehydrogenase type 1 as a therapeutic target for type 2 diabetes / Clarence Hale and David J. St. Jean, Jr -- Monoclonal antibodies for the treatment of type 2 diabetes : a case study with glucagon receptor blockade / Hai Yan, Wei Gu, and Murielle Veniant-Ellison -- Drug development for metabolic diseases: past, present and future / Minghan Wang. 
533 |a Electronic reproduction.  |b Palo Alto, Calif. :  |c ebrary,  |d 2011.  |n Available via World Wide Web.  |n Access may be limited to ebrary affiliated libraries. 
650 0 |a Metabolic syndrome  |x Pathophysiology. 
650 0 |a Metabolic syndrome  |x Chemotherapy. 
655 7 |a Electronic books.  |2 local 
700 1 |a Wang, Minghan,  |d 1966- 
710 2 |a ebrary, Inc. 
856 4 0 |u http://site.ebrary.com/lib/daystar/Doc?id=10441458  |z An electronic book accessible through the World Wide Web; click to view 
908 |a 170314 
942 0 0 |c EB 
999 |c 119246  |d 119246